Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.



  • Veni grants for three NKI researchers

    Gerbrand van der Heden, Micha Nethe and Babet van der Vaart will each receive a Veni grant from the Netherlands Organization for Scientific Research (NWO). The grant money is 250.000 Euros.

    Read More
  • Genetic profiling predicts breast cancer drug susceptibility

    A team of NKI researchers, headed by prof. dr. René Bernards and dr. Wilbert Zwart, have developed a genetic profile that can be used to predict which breast cancer patients are susceptible to treatment with Tamoxifen.

    Read More
  • More news

Comprehensive Cancer Centre

'The Netherlands Cancer Institute, a center of excellence for the benefit of cancer patients.'

Support Us